China’s drug regulator clears mpox vaccine; Clinical trials to begin soon
China approves Sinopharm's MVA-based mpox vaccine for clinical trials, aiming to combat the disease and prevent further outbreaks. The country has expedited vaccine approvals, while globally, only a few countries have approved mpox vaccines. The World Health Organization has declared the outbreak a public health emergency, with over 120 countries affected.